COMP <GO>
ENSG vs THC // 10Y YIELD & FRED MACRO BETA
The Ensign Group Inc. (NASDAQ) VS. Tenet Healthcare Corporation (NYSE) • 15-METRIC TALLY: ENSG 5
— THC 8
▲ 10Y YIELD & FRED MACRO BETA LEADER: THC
LAST: $181.52 (-2.58%) • MKT CAP: $10.87B
macro-sensitivity
0.89
LAST: $273.25 (+0.99%) • MKT CAP: $21.79B
macro-sensitivity
0.97
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENSG VS. THC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ENSG | THC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.00% | 27.60% | -9.60 | THC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 6.3x | +10.70 | THC | /valuation <GO> |
| Free Cash Flow Yield | 3.11% | 11.61% | -8.50 | THC | /fcf-yield <GO> |
| Operating Margin | 8.50% | 16.50% | -8.00 | THC | /operating-margins <GO> |
| Net Profit Margin | 6.80% | 11.10% | -4.30 | THC | /net-margins <GO> |
| Revenue Growth (YoY) | 18.80% | 3.10% | +15.70 | ENSG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.13% | 0.00% | +0.13 | ENSG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.73 | 2.08 | +1.65 | ENSG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | ENSG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.2 | 54.8 | +5.40 | ENSG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.89 | 0.97 | -0.08 | THC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 8.6x | +17.90 | THC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.87B | $21.79B | -$10.92B | THC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ENSG REV | THC REV | ENSG GROSS % | THC GROSS % | ENSG FCF | THC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.03B | $21.31B | 20.1% | — | $337.8M | $2.53B |
| FY 2024 | $4.24B | $20.68B | 20.3% | — | $156.5M | $1.12B |
| FY 2023 | $3.71B | $20.56B | — | — | $209.8M | $1.45B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENSG // BETA 0.89
THC // BETA 0.97